Product Categories
| Country: | China |
|---|---|
| Tel: | 0755-66853366 |
| Mobile: | 13670046396 |
| E-mail: | orders@qcsrm.com |
| QQ: | 2851296956 |
| Skype: | Chat Now! |
| Address: | B1-203 & B3-402 Life Science Park SCT Creative Factory, Pingshan District ShenZhen, China |
| Product Name | MF | CAS | Details |
|---|
| Lenalidomide Impurity 57 | C9H9NO4 | 77324-87-9 | Details |
| Linagliptin Impurity 66 | C30H36N8O4 | 668273-75-4 | Details |
| Lenalidomide Impurity 56 | C13H15N3O4 | 2197414-57-4 | Details |
| Lamivudine Impurity 21 | C18H27N3O4S | 147027-10-9 | Details |
| Lincomycin Hydrochloride EP Impurity C | C17H32N2O6S.ClH | 14600-41-0 | Details |
| Linagliptin Impurity G | C25H28N8O2 | 668270-11-9 | Details |
| Linagliptin Impurity 68 | C54H62N16O4 | 1643364-41-3 | Details |
| Linagliptin Impurity N | C25H29N7O4 | 2416949-69-2 | Details |
| Linagliptin Impurity E | C25H28N8O2 | 1446263-38-2 | Details |
| Linagliptin | C25H28N8O2 | 668270-12-0 | Details |
| Lenalidomide Impurity C | C13H15N3O4 | 2197420-75-8 | Details |
| Lenalidomide Impurity B | C9H8ClNO4 | 1218910-61-2 | Details |
| Lenalidomide | C13H13N3O3 | 191732-72-6 | Details |
| Linagliptin Acetamide | C27H30N8O3 | 1803079-49-3 | Details |
| Lamivudine EP Impurity H | C8H11N3O4S | 160552-54-5 | Details |
| Lamivudine EP Impurity J | C8H10N2O4S | 145986-07-8 | Details |
| Lamivudine EP Impurity I | C8H11N3O4 | 145918-75-8 | Details |
| Lamivudine Impurity 1 | C8H11N3O3S | 136846-20-3 | Details |
| Lenalidomide Impurity 46 | C9H8BrNO4 | 98475-07-1 | Details |
| Lenalidomide Impurity 43 | C14H13N3O4 | 2197414-56-3 | Details |
| Linagliptin Impurity T(Linagliptin Methyldimer) | C50H56N16O4 | 1418133-47-7 | Details |
| Linagliptin Impurity R | C22H23N7O2 | 1646355-34-1 | Details |
| (R)-(+)-Limonene | C10H16 | 5989-27-5 | Details |
| Levetiracetam EP Impurity C | C5H5NO | 142-08-5 | Details |
| Levosimendan Impurity 6 | C11H13N3O | 101328-85-2 | Details |
| Levofloxacin EP Impurity B; Levofloxacin Related Compound A | C17H18FN3O4 | 117707-40-1 | Details |
| Lafutidine Impurity 13 | C15H23N3O | 103922-84-5 | Details |
| Lafutidine Sulfone | C22H29N3O5S | 174583-84-7 | Details |
| Lafutidine Phthalimide Impurity | C27H29N3O7 | 146447-26-9 | Details |
| Levodropropizine EP Impurity B | C10H14N2 | 92-54-6 | Details |
| Levocetirizine Impurity 2 | C17H19ClN2 | 300543-56-0 | Details |
| Levocetirizine Impuritya; USP Levocetirizine Amide | C21H26ClN3O2 | 909779-33-5 | Details |
| Leuprolide(Leuprorelin) EP Impurity I | C59H84N16O12 | 1926163-26-9 | Details |
| Levofloxacin EP Impurity F; USP Levofloxacin Related Compound B | C13H9F2NO4 | 100986-89-8 | Details |
| Levofloxacin EP Impurity H; USP Levofloxacin Related Compound C | C20H24FN3O4 | 177472-30-9 | Details |
| Lipoic Acid Impurity 24 | C10H16O3 | 50628-92-7 | Details |
| Lipoic Acid Impurity 33 | C8H14O3S2 | 188745-24-6 | Details |
| Lipoic Acid Impurity 36 | C8H14O3S2 | 188783-96-2 | Details |
| Levofloxacin Desethylene Diformyl Impurity | C18H18FN3O6 | 151377-74-1 | Details |
| Levofloxacin EP Impurity I | C18H20FN3O4 | 178912-62-4 | Details |
| Levofloxacin Impurity N | C13H11F2NO4 | 1026952-91-9 | Details |
| Levofloxacin Impurity 7 | C18H20FN3O5 | 117678-37-2 | Details |
| Levofloxacin Impurity 10 | C15H13F2NO4 | 106939-34-8 | Details |
| Levofloxacin Impurity 19 | C15H16FN3O4 | 1797510-34-9 | Details |
| Levofloxacin Impurity 6 | C23H31N5O4 | 1329833-82-0 | Details |
| Levofloxacin EP Impurity C; USP Levofloxacin Related Compound C | C18H20FN3O5 | 117678-38-3 | Details |
| Lipoic Acid Impurity 4 | C8H14O4S2 | 17370-41-1 | Details |
| Lipoic Acid Impurity 34 | C10H18O2S3 | 2635383-46-7 | Details |
| Levofloxacin Impurity 22 | C20H25F2N3O4 | 177472-29-6 | Details |
| Levofloxacin EP Impurity G; USP Levofloxacin Related Compound E | C16H18FN3O4 | 151250-76-9 | Details |
| Levofloxacin EP Impurity E | C17H20FN3O2 | 178964-53-9 | Details |
| Levofloxacin EP Impurity D; USP Levofloxacin Related Compound F | C18H21N3O4 | 117620-85-6 | Details |
| Levofloxacin EP Impurity A; R-Ofloxacin | C18H20FN3O4 | 100986-86-5 | Details |
| Eslicarbazepine Acetate | C17H16N2O3 | 236395-14-5 | Details |
| Licarbazepine | C15H14N2O2 | 29331-92-8 | Details |
| Liraglutide | C172H265N43O51 | 204656-20-2 | Details |
| Leuprolide(Leuprorelin) EP Impurity H | C59H84N16O12 | 112710-58-4 | Details |
| Leuprolide(Leuprorelin) EP Impurity G | C59H84N16O12 | 112710-57-3 | Details |
| Leuprolide(Leuprorelin) EP Impurity F | C59H84N16O12 | 1872435-00-1 | Details |
| Leuprolide(Leuprorelin) EP Impurity E | C59H84N16O12 | 1926163-23-6 | Details |
| Leuprolide(Leuprorelin) EP Impurity D | C61H86N16O13 | 1926163-25-8 | Details |
| Leuprolide(Leuprorelin) EP Impurity C | C59H84N16O12 | 54785-87-4 | Details |
| Leuprolide(Leuprorelin) EP Impurity B | C59H84N16O12 | 112642-11-2 | Details |
| Leuprolide(Leuprorelin) EP Impurity A | C59H84N16O12 | 62621-13-0 | Details |
| Lipoic Acid Impurity 22 | C8H14O2S | 25636-58-2 | Details |
| Lipoic Acid Impurity 3; Rac-Lipoic Acid Impurity 1 (S-Oxide) | C8H14O3S2 | 108015-78-7 | Details |
| Lipoic Acid Impurity A | C10H20N2OS2 | 728854-75-9 | Details |
| Lifitegrast Impurity 32 | C11H10O3 | 1289646-90-7 | Details |
| Lifitegrast Impurity 12 | C9H6O3 | 77095-51-3 | Details |
| Lifitegrast Impurity 5 | C29H24Cl2N2O7S | 2271299-08-0 | Details |
| Lifitegrast | C29H24Cl2N2O7S | 1025967-78-5 | Details |
| Lamivudine EP Impurity D | C8H11N3O3S | 134680-32-3 | Details |
| Lamivudine EP Impurity E; Gemcitabine EP Impurity A | C4H5N3O | 71-30-7 | Details |
| Lamivudine EP Impurity G | C8H11N3O4S | 160552-55-6 | Details |
| Lansoprazole EP Impurity C | C16H14F3N3OS | 103577-40-8 | Details |
| Lansoprazole Impurity K(Lansoprazole Sulfide N-Oxide) | C16H14F3N3O2S | 163119-30-0 | Details |
| Lansoprazole Sulfone N-Oxide | C16H14F3N3O4S | 953787-54-7 | Details |
| Lansoprazole Impurity P | C25H22F6N4O3S | 1083100-26-8 | Details |
| Lansoprazole Impurity 1 | C9H9ClF3NO2 | 163119-28-6 | Details |
| Lansoprazole Impurity 3 | C25H22F6N4O2S | 1083100-27-9 | Details |
| Linezolid Impurity 38 | C14H18FN3O4 | 1219708-30-1 | Details |
| Lomefloxacin Impurity 1 | C17H18FN3O3 | 195259-11-1 | Details |
| Levosimendan | C14H12N6O | 141505-33-1 | Details |
| Levosimendan Impurity 11 | C14H12N6O | 144238-75-5 | Details |
| Levosimendan Impurity 14 | C14H11N7O2 | 252638-01-0 | Details |
| Levetiracetam | C8H14N2O2 | 102767-28-2 | Details |
| Levetiracetam USP Rc A | C8H15ClN2O2 | 102767-31-7 | Details |
| Levetiracetam Carboxylic Acid | C8H13NO3 | 102849-49-0 | Details |
| Levetiracetam USP Rc B | C4H10N2O | 7324-11-0 | Details |
| Levetiracetam Impurity 2 | C8H14N2O2 | 33996-58-6 | Details |
| Levetiracetam Impurity 6 | C8H17N3O2 | 1867585-44-1 | Details |
| Levetiracetam Impurity 14 | C8H16N2O3 | 1868118-63-1 | Details |
| Levetiracetam EP Impurity A | C8H13NO3 | 67118-31-4 | Details |
| Levetiracetam EP Impurity B | C8H12N2O2 | 358629-47-7 | Details |
| Levetiracetam EP Impurity D | C8H14N2O2 | 103765-01-1 | Details |
| Levosimendan Cyanoacetamide Hydrazone Impurity | C14H14N6O2 | 274263-65-9 | Details |
| Levosimendan Impurity 3 | C30H30N12O3 | 618458-79-0 | Details |
| Levosimendan Impurity 24 | C14H12N6O | 131741-08-7 | Details |
| Lincomycin Hydrochloride EP Impurity F | C9H19NO5S | 14810-93-6 | Details |
| Lipoic Acid Impurity 11 (Impurity D) | C8H14O3S2 | 2114407-76-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 | ||||